VHL and von Hippel-Lindau disease: In fact, RSUME is able to promote SUMOylation of VHL mutated variants observed in VHL syndrome, but also abrogates HIF-2α degradation by interacting with these VHL variants in a VHL-SUMOylation independent way (16).